While GFAP fragmentation plays a physiological role in astrocyte remodelling, its dysregulation has been linked to neurodegenerative diseases such as AD [196, 197], amyotrophic lateral sclerosis [198], and TBI [132, 194]. This evidence concerns the gene GFAP and neurodegenerative disease.